COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 1563: Articles 15621-15630  | Next

A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope
VanBlargan, L., Adams, L., Liu, Z., Chen, R. E., Gilchuk, P., Raju, S., Smith, B., Zhao, H., Case, J. B., Winkler, E. S., Whitener, B., Droit, L., Aziati, I., Shi, P.-Y., Creanga, A., Pegu, A., Handley, S., Wang, D., Boon, A., Crowe, J. E., Whelan, S. P. J., Fremont, D., Diamond, M.
10.1101/2021.04.26.441501 — Posted: 2021-04-26
A SARS CoV-2 nucleocapsid vaccine protects against distal viral dissemination
Class, J., Dangi, T., Richner, J., Penaloza-MacMaster, P.
10.1101/2021.04.26.440920 — Posted: 2021-04-26
Control-theoretic immune tradeoffs explain SARS-CoV-2 virulence and transmission variation
Sarma, A. A., Sarma, A., Csete, M., Lee, P. P., Doyle, J. C.
10.1101/2021.04.25.441372 — Posted: 2021-04-26
Production of a Highly Immunogenic Antigen from SARS-CoV-2 by Covalent Coupling of the Receptor Binding Domain of Spike Protein to a Multimeric Carrier
Argentinian AntiCovid Consortium, , Berguer, P. M., Blaustein, M., Bredeston, L., Craig, P. O., D'Alessio, C., Elias, F., Farre, P. C., Fernandez, N. B., Gentili, H. G., Gandola, Y., Gasulla, J., Gudesblat, G. E., Herrera, M. G., Ibanez, L. I., Idrovo-Hidalgo, T., Nadra, A. D., Noseda, D. G., Pavan, C. H., Pavan, M. F., Pignataro, M. F., Roman, E., Ruberto, L. A. M., Rubinstein, N., Sanchez, M. V., Santos, J., Wetzler, D. E., Zelada, A. M.
10.1101/2021.04.25.441271 — Posted: 2021-04-26
6-Month Follow Up of 8679 Hospitalized COVID-19 Patients in Germany: A Nationwide Cohort Study
Guenster, C., Busse, R., Spoden, M., Rombey, T., Schillinger, G., Hoffmann, W., Weber-Carstens, S., Schuppert, A., Karagiannidis, C.
10.1101/2021.04.24.21256029 — Posted: 2021-04-26 Discussion: Offsite
Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada
Gates, M., Pillay, J., Wingert, A., Guitard, S., Rahman, S., Zakher, B., Gates, A., Hartling, L.
10.1101/2021.04.23.21256014 — Posted: 2021-04-26
Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru
Diaz, M. M., Cabrera, D. M., Gil-Zacarias, M., Ramirez, V., Saavedra, M., Carcamo, C., Hsieh, E., Garcia, P. J.
10.1101/2021.04.23.21255998 — Posted: 2021-04-26
Reopen or redistribute? Modeling years of life lost due to Covid-19, socioeconomic status, and non-pharmaceutical interventions
John, J.
10.1101/2021.04.23.21256005 — Posted: 2021-04-26
Depression during the COVID-19 pandemic amongst residents of homeless shelters in France.
Scarlett, H., Davisse-Paturet, C., Longchamps, C., El Aarbaoui, T., Allaire, C., Colleville, A.-C., Convence-Arulthas, M., Crouzet, L., Ducarroz, S., Melchior, M.
10.1101/2021.04.23.21255993 — Posted: 2021-04-26
Fatigue symptoms associated with COVID-19 in convalescent or recovered COVID-19 patients; a systematic review and meta-analysis
Rao, S., Benzouak, T., Gunpat, S., Burns, R. J., Tahir, T. A., Jolles, S., Kisely, S.
10.1101/2021.04.23.21256006 — Posted: 2021-04-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).